CD8A and neoplasm: Unlike bulk RNA-seq or microarray platforms, scRNA-seq provides higher precision by enabling cell-level resolution [12,13], allowing the identification of immune cell subtypes and their interactions within tumor samples, such as exhausted CD8 + T cells and FCGR3A+ macrophages in liver cancer [14].